期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 202, 期 12, 页码 1643-1648出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20051984
关键词
-
资金
- NCIPC CDC HHS [U17 CE002006] Funding Source: Medline
The Journal of Experimental Medicine Because most autoimmune diseases are polygenic, analysis of the synergistic involvement of various immune regulators is essential for a complete understanding of the molecular pathology of these diseases. We report the regulation of autoimmune diseases by epistatic effects of two immunoinhibitory receptors, low affinity type IIb Fc receptor for IgG (Fc gamma RIIB) and programmed cell death 1 (PD-1). Approximately one third of the BALB/c-Fcgr2b(-/-) Pdcd1(-/-) mice developed autoimmune hydronephrosis, which is not observed in either BALB/c-Fcgr2b(-/-) or BALB/c-Pdcd1(-/-) mice. Hydronephrotic mice produced autoantibodies (autoAbs) against urothelial antigens, including uroplakin IIIa, and these antibodies were deposited on the urothelial cells of the urinary bladder. In addition, similar to 15% of the BALB/c-Fcgr2b(-/-) Pdcd1(-/-) mice produced antinuclear autoAbs. In contrast, the frequency of the autoimmune cardiomyopathy and the production of anti-parietal cell autoAb, which were observed in BALB/c-Pdcd1(-/-) mice, were not affected by the additional Fc gamma RIIB deficiency. These observations suggest cross talk between two immunoinhibitory receptors, Fc gamma RIIB and PD-1, on the regulation of autoimmune diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据